Byvalson
NDC Package 0023-5874-84

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Byvalson is a medication used to treat high blood pressure. Marketed by Allergan, Inc., this product is identified by NDC 0023-5874 and is authorized under FDA application NDA206302.

Identification & Billing

NDC Package Code
0023-5874-84
Package Description
5 BLISTER PACK in 1 TRAY / 7 TABLET, FILM COATED in 1 BLISTER PACK (0023-5874-07)
Product Code
0023-5874
11-Digit Billing Format
00023587484

Clinical Specifications

Proprietary Name
Byvalson
Dosage Form
-
Usage Information
This product is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains 2 medications: nebivolol and valsartan. Nebivolol belongs to a class of drugs known as beta blockers. Valsartan belongs to a class of drugs known as angiotensin receptor blockers (ARBs). Nebivolol works by blocking the action of certain natural substances in your body, such as epinephrine, on the heart and blood vessels. This effect lowers heart rate, blood pressure, and strain on the heart. Valsartan works by relaxing blood vessels so blood can flow more easily.

Regulatory & Marketing

Labeler Name
Allergan, Inc.
FDA Application #
NDA206302
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-03-2016
End Marketing Date
05-31-2019
Listing Expiration
05-31-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0023-5874). Click a package code to view its specific billing and regulatory data.

0023-5874-30
30 TABLET, FILM COATED in 1 BOTTLE
0023-5874-32
5 BOTTLE in 1 TRAY / 30 TABLET, FILM COATED in 1 BOTTLE (0023-5874-31)
0023-5874-90
90 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0023-5874-84 identifies a specific commercial package of 5 blister pack in 1 tray / 7 tablet, film coated in 1 blister pack (0023-5874-07) of Byvalson, labeled by Allergan, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Allergan, Inc. on June 03, 2016. The current certification is valid through May 31, 2019.

What are the primary indications for this medication?

This product is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains 2 medications: nebivolol and valsartan. Nebivolol belongs to a class of drugs known as beta blockers. Valsartan belongs to a class of drugs known as angiotensin receptor blockers (ARBs). Nebivolol works by blocking the action of certain natural substances in your body, such as epinephrine, on the heart and blood vessels. This effect lowers heart rate, blood pressure, and strain on the heart. Valsartan works by relaxing blood vessels so blood can flow more easily.

How is this Allergan, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00023587484. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0023-5874-84
11-Digit CMS (5-4-2)
00023-5874-84

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.